Regulation of gene expression by retinoids

Current Medicinal Chemistry

Volumn 18, Issue 9, 2011, Pages 1405-1412

  P M Amann, ^a,b   Eichmuller S B ^a,b   Schmidt, J ^c   Bazhin, A V ^a,b,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Gene expression; Retinal; Retinoic acid; Retinoic acid receptor; Retinol

Indexed keywords

3,7 DIMETHYL 9 (2,6,6 TRIMETHYLCYCLOHEX 1 EN 1 YL)NOMA 2,4,6,8 TETRAEN I OL; ALDEHYDE DERIVATIVE; BETA CAROTENE; CAROTENOID; RETINAL; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID DERIVATIVE; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; RETINOL; RETINOL DERIVATIVE; STEROID RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; DNA RESPONSIVE ELEMENT; DRUG STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR MECHANICS; NIGHT VISION; NONHUMAN; PHOTOSENSITIVITY; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RETINOIC ACID RESPONSIVE ELEMENT; SIGNAL TRANSDUCTION;

DNA; GENE EXPRESSION REGULATION; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, RETINOIC ACID; RETINALDEHYDE; RETINOID X RECEPTORS; RETINOIDS; VITAMIN A;

EID: 79952806384     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795029618     Document Type: Article

References (114)

1. Wald, G. Molecular basis of visual excitation. Science, 1968, 162(850), 230-239.
2. De Luca, L.M. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J., 1991, 5(14), 2924-2933. (Pubitemid 21905833)
3. Jarrett, A.; Spearman, R.I. Vitamin A and the skin. Br. J. Dermatol., 1970, 82(2), 197-199.
4. Ross, S.A.; McCaffery, P.J.; Drager, U.C.; De Luca, L.M. Retinoids in embryonal development. Physiol. Rev., 2000, 80(3), 1021-1054. (Pubitemid 30452010)
5. Funk, C. The effect of a diet of polished rice on the nitrogen and phosphorus of the brain. J. Physiol., 1912, 44(1-2), 50-53.
6. Wolf, G. The discovery of the visual function of vitamin A. J. Nutri., 2001, 131(6), 1647-1650. (Pubitemid 32520427)
7. Drummond, J.C. The Nomenclature of the so-called Accessory Food Factors (Vitamins). Biochem. J., 1920, 14(5), 660.
8. Arens, J.F.; Van Dorp, D.A. [Not Available]. Produits Pharmaceut., 1949, 4(6), 249; passim.
9. Harrison, E.H. Mechanisms of digestion and absorption of dietary vitamin A. Ann. Rev. Nut., 2005, 25, 87-103. (Pubitemid 41208995)
10. Nomenclature of retinoids. Recommendations 1981. Eur. J. Biochem., 1982, 129(1), 1-5.
11. Bempong, D.K.; Honigberg, I.L.; Meltzer, N.M. Normal phase LC-MS determination of retinoic acid degradation products. J. Pharm. Biomed. Anal., 1995, 13(3), 285-291.
12. Dawson, M.I.; Hobbs, P.D.; Chan, R.L.; Chao, W.R. Retinoic acid analogues with ring modifications. Synthesis and pharmacological activity. J. Med. Chem., 1981, 24(10), 1214-1223. (Pubitemid 12163440)
13. Dawson, M.I.; Hobbs, P.D.; Chan, R.L.; Chao, W.R.; Fung, V.A. Aromatic retinoic acid analogues. Synthesis and pharmacological activity. J. Med. Chem., 1981, 24(5), 583-592. (Pubitemid 11021895)
14. Christie, V.B.; Barnard, J.H.; Batsanov, A.S.; Bridgens, C.E.; Cartmell, E.B.; Collings, J.C.; Maltman, D.J.; Redfern, C.P.; Marder, T.B.; Przyborski, S.; Whiting, A. Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiation. Org. Biomol. Chem., 2008, 6(19), 3497-3507.
15. Suzuki, T.; Kunchala, S.R.; Matsui, M.; Murayama, A. Molecular flexibility of retinoic acid under white fluorescent light. J. Nut. Sci. Vitaminol., 1998, 44(6), 729-736. (Pubitemid 29091140)
16. Robeson, C.; Blum, W.; Dieterle, J.; Cawley, J.; Baxter, L. Chemistry of Vitamin A. XXV. Geometrical Isomers of Vitamin A Aldehyde and an Isomer of its a-Ionone Analog. J. Am. Chem. Soc., 1955, 77(15), 4120-4125.
17. Kiefer, C.; Hessel, S.; Lampert, J.M.; Vogt, K.; Lederer, M.O.; Breithaupt, D.E.; von Lintig, J. Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A. J. Biol. Chem., 2001, 276(17), 14110-14116.
18. Robinson-Rechavi, M.; Escriva Garcia, H.; Laudet, V. The nuclear receptor superfamily. J. Cell Sci., 2003, 116(Pt 4), 585-586. (Pubitemid 36231296)
19. McGrane, M.M. Vitamin A regulation of gene expression: Molecular mechanism of a prototype gene. J. Nut. Biochem., 2007, 18(8), 497-508. (Pubitemid 47043417)
20. Blomhoff, R.; Blomhoff, H.K. Overview of retinoid metabolism and function. J. Neurobiol., 2006, 66(7), 606-630. (Pubitemid 43941649)
21. Ziouzenkova, O.; Plutzky, J. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett., 2008, 582(1), 32-38. (Pubitemid 50019948)
22. Mongan, N.P.; Gudas, L.J. Diverse actions of retinoid receptors in cancer prevention and treatment. Differ. Res. Biol. Diver., 2007, 75(9), 853-870. (Pubitemid 350086170)
23. Giguere, V.; Ong, E.S.; Segui, P.; Evans, R.M. Identification of a receptor for the morphogen retinoic acid. Nature, 1987, 330(6149), 624-629. (Pubitemid 18005577)
24. Petkovich, M.; Brand, N.J.; Krust, A.; Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature, 1987, 330(6147), 444-450. (Pubitemid 18006425)
25. Mangelsdorf, D.J.; Ong, E.S.; Dyck, J.A.; Evans, R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature, 1990, 345(6272), 224-229.
26. Mangelsdorf, D.J.; Thummel, C.; Beato, M.; Herrlich, P.; Schutz, G.; Umesono, K.; Blumberg, B.; Kastner, P.; Mark, M.; Chambon, P.; Evans, R.M. The nuclear receptor superfamily: The second decade. Cell, 1995, 83(6), 835-839.
27. Leid, M.; Kastner, P.; Chambon, P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci., 1992, 17(10), 427-433.
28. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 1996, 10(9), 940-954. (Pubitemid 26285969)
29. Hind, M.; Corcoran, J.; Maden, M. Temporal/spatial expression of retinoid binding proteins and RAR isoforms in the postnatal lung. Am. J. Physiol., 2002, 282(3), L468-476. (Pubitemid 34654649)
30. Heyman, R.A.; Mangelsdorf, D.J.; Dyck, J.A.; Stein, R.B.; Eichele, G.; Evans, R.M.; Thaller, C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 1992, 68(2), 397-406.
31. Levin, A.A.; Sturzenbecker, L.J.; Kazmer, S.; Bosakowski, T.; Huselton, C.; Allenby, G.; Speck, J.; Kratzeisen, C.; Rosenberger, M.; Lovey, A.; Grippo, J.F. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature, 1992, 355(6358), 359-361.
32. Yang, N.; Schule, R.; Mangelsdorf, D.J.; Evans, R.M. Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor. Proc. Natl. Acad. Sci. U.S.A., 1991, 88(9), 3559-3563. (Pubitemid 21916662)
33. Kastner, P.; Mark, M.; Ghyselinck, N.; Krezel, W.; Dupe, V.; Grondona, J.M.; Chambon, P. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development (Cambridge, England), 1997, 124(2), 313-326. (Pubitemid 27101666)
34. Kliewer, S.A.; Umesono, K.; Mangelsdorf, D.J.; Evans, R.M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature, 1992, 355(6359), 446-449.
35. Kliewer, S.A.; Umesono, K.; Noonan, D.J.; Heyman, R.A.; Evans, R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature, 1992, 358(6389), 771-774.
36. Forman, B.M.; Umesono, K.; Chen, J.; Evans, R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell, 1995, 81(4), 541-550.
37. Fisher, G.J.; Voorhees, J.J. Molecular mechanisms of retinoid actions in skin. FASEB J., 1996, 10(9), 1002-1013. (Pubitemid 26285976)
38. Niles, R.M. Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat. Res., 2004, 555(1-2), 81-96. (Pubitemid 39359177)
39. Rochette-Egly, C. Nuclear receptors: Integration of multiple signalling pathways through phosphorylation. Cell Signal., 2003, 15(4), 355-366. (Pubitemid 36254908)
40. Renaud, J.P.; Moras, D. Structural studies on nuclear receptors. Cell Mol. Life Sci., 2000, 57(12), 1748-1769.
41. Zechel, C.; Shen, X.Q.; Chen, J.Y.; Chen, Z.P.; Chambon, P.; Gronemeyer, H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the fulllength receptors to direct repeats. EMBO J., 1994, 13(6), 1425-1433. (Pubitemid 24090224)
42. Yu, Z.; Lee, C.H.; Chinpaisal, C.; Wei, L.N. A constitutive nuclear localization signal from the second zinc-finger of orphan nuclear receptor TR2. J. Endocrinol., 1998, 159(1), 53-60. (Pubitemid 28459266)
43. Moras, D.; Gronemeyer, H. The nuclear receptor ligand-binding domain: Structure and function. Curr. Opin. Cell Biol., 1998, 10(3), 384-391. (Pubitemid 28287050)
44. Egea, P.F.; Rochel, N.; Birck, C.; Vachette, P.; Timmins, P.A.; Moras, D. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J. Mol. Biol., 2001, 307(2), 557-576. (Pubitemid 33028932)
45. Rochette-Egly, C.; Oulad-Abdelghani, M.; Staub, A.; Pfister, V.; Scheuer, I.; Chambon, P.; Gaub, M.P. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol. Endocrinol. Baltimore Md., 1995, 9(7), 860-871.
46. Bastien, J.; Rochette-Egly, C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene, 2004, 328, 1-16. (Pubitemid 38352876)
47. Rastinejad, F. Retinoid X receptor and its partners in the nuclear receptor family. Curr. Opin. Struct. Biol., 2001, 11(1), 33-38. (Pubitemid 32155549)
48. Lefebvre, P.; Martin, P.J.; Flajollet, S.; Dedieu, S.; Billaut, X.; Lefebvre, B. Transcriptional activities of retinoic acid receptors. Vitam. Horm., 2005, 70, 199-264. (Pubitemid 43589019)
49. Dilworth, F.J.; Chambon, P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene, 2001, 20(24), 3047-3054. (Pubitemid 32553559)
50. Glass, C.K.; Rosenfeld, M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev., 2000, 14(2), 121-141. (Pubitemid 30070977)
51. Heery, D.M.; Kalkhoven, E.; Hoare, S.; Parker, M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature, 1997, 387(6634), 733-736. (Pubitemid 27270617)
52. Hu, X.; Lazar, M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature, 1999, 402(6757), 93-96.
53. McKenna, N.J.; O'Malley, B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 2002, 108(4), 465-474. (Pubitemid 34260872)
54. Chen, H.; Lin, R.J.; Xie, W.; Wilpitz, D.; Evans, R.M. Regulation of hormone- induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell, 1999, 98(5), 675-686. (Pubitemid 29418958)
55. Malik, S.; Roeder, R.G. Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells. Trends Biochem. Sci., 2000, 25(6), 277-283. (Pubitemid 30333386)
56. Kopf, E.; Plassat, J.L.; Vivat, V.; de The, H.; Chambon, P.; Rochette-Egly, C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J. Biol. Chem., 2000, 275(43), 33280-33288.
57. Gianni, M.; Bauer, A.; Garattini, E.; Chambon, P.; Rochette-Egly, C. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RAinduced RAR gamma degradation and transactivation. EMBO J., 2002, 21(14), 3760-3769. (Pubitemid 34787049)
58. Hong, S.H.; Privalsky, M.L. The SMRT corepressor is regulated by a MEK- 1 kinase pathway: Inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol. Cell Biol., 2000, 20(17), 6612-6625. (Pubitemid 30650245)
59. Chen, J.Y.; Penco, S.; Ostrowski, J.; Balaguer, P.; Pons, M.; Starrett, J.E.; Reczek, P.; Chambon, P.; Gronemeyer, H. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorageindependent cell proliferation. EMBO J., 1995, 14(6), 1187-1197.
60. Pfahl, M. Nuclear receptor/AP-1 interaction. Endocr. Rev., 1993, 14(5), 651-658. (Pubitemid 23320391)
61. Hirose, T.; Apfel, R.; Pfahl, M.; Jetten, A.M. The orphan receptor TAK1 acts as a repressor of RAR-, RXR- And T3R-mediated signaling pathways. Biochem. Biophys. Res. Commun., 1995, 211(1), 83-91.
62. Cooney, A.J.; Tsai, S.Y.; O'Malley, B.W.; Tsai, M.J. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone, and retinoic acid receptors. Mol. Cell Biol., 1992, 12(9), 4153-4163.
63. Bocchia, M.; Xu, Q.; Wesley, U.; Xu, Y.; Korontsvit, T.; Loganzo, F.; Albino, A.P.; Scheinberg, D.A. Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells. Leukemia Res., 1997, 21(5), 439-447. (Pubitemid 27308240)
64. Sueoka, N.; Lee, H.Y.; Walsh, G.L.; Hong, W.K.; Kurie, J.M. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells. Cancer Res., 1999, 59(15), 3838-3844. (Pubitemid 29381894)
65. Suzui, M.; Shimizu, M.; Masuda, M.; Lim, J.T.; Yoshimi, N.; Weinstein, I.B. Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells. Mol. Cancer Ther., 2004, 3(3), 309-316. (Pubitemid 39193706)
66. Altucci, L.; Rossin, A.; Raffelsberger, W.; Reitmair, A.; Chomienne, C.; Gronemeyer, H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat. Med., 2001, 7(6), 680-686. (Pubitemid 32588023)
67. Xiao, S.; Li, D.; Zhu, H.Q.; Song, M.G.; Pan, X.R.; Jia, P.M.; Peng, L.L.; Dou, A.X.; Chen, G.Q.; Chen, S.J.; Chen, Z.; Tong, J.H. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc. Natl. Acad. Sci. U.S.A., 2006, 103(44), 16448-16453. (Pubitemid 44715216)
68. Yin, W.; Rossin, A.; Clifford, J.L.; Gronemeyer, H. Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene, 2006, 25(26), 3735-3744. (Pubitemid 43980494)
69. Nagy, L.; Thomazy, V.A.; Heyman, R.A.; Davies, P.J. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ., 1998, 5(1), 11-19. (Pubitemid 28359078)
70. Cawley, S.; Bekiranov, S.; Ng, H.H.; Kapranov, P.; Sekinger, E.A.; Kampa, D.; Piccolboni, A.; Sementchenko, V.; Cheng, J.; Williams, A.J.; Wheeler, R.; Wong, B.; Drenkow, J.; Yamanaka, M.; Patel, S.; Brubaker, S.; Tammana, H.; Helt, G.; Struhl, K.; Gingeras, T.R. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell, 2004, 116(4), 499-509. (Pubitemid 38264428)
71. Fu, P.P.; Xia, Q.; Boudreau, M.D.; Howard, P.C.; Tolleson, W.H.; Wamer, W.G. Physiological role of retinyl palmitate in the skin. Vitam. Horm., 2007, 75, 223-256.
72. Hoyos, B.; Imam, A.; Korichneva, I.; Levi, E.; Chua, R.; Hammerling, U. Activation of c-Raf kinase by ultraviolet light. Regulation by retinoids. J. Biol. Chem., 2002, 277(26), 23949-23957. (Pubitemid 34952240)
73. Pasonen-Seppanen, S.M.; Maytin, E.V.; Torronen, K.J.; Hyttinen, J.M.; Hascall, V.C.; MacCallum, D.K.; Kultti, A.H.; Jokela, T.A.; Tammi, M.I.; Tammi, R.H. All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes. J. Invest. Dermatol., 2008, 128(4), 797-807. (Pubitemid 351374294)
74. Ziouzenkova, O.; Orasanu, G.; Sharlach, M.; Akiyama, T.E.; Berger, J.P.; Viereck, J.; Hamilton, J.A.; Tang, G.; Dolnikowski, G.G.; Vogel, S.; Duester, G.; Plutzky, J. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat. Med., 2007, 13(6), 695-702. (Pubitemid 46889756)
75. Duester, G. Families of retinoid dehydrogenases regulating vitamin A function: Production of visual pigment and retinoic acid. Eur. J. Biochem., 2000, 267(14), 4315-4324. (Pubitemid 30461062)
76. Napoli, J.L.; Race, K.R. Biogenesis of retinoic acid from beta-carotene. Differences between the metabolism of beta-carotene and retinal. J. Biol. Chem., 1988, 263(33), 17372-17377.
77. Napoli, J.L. Retinoic acid biosynthesis and metabolism. FASEB J., 1996, 10(9), 993-1001. (Pubitemid 26285975)
78. Jang, G.F.; McBee, J.K.; Alekseev, A.M.; Haeseleer, F.; Palczewski, K. Stereoisomeric specificity of the retinoid cycle in the vertebrate retina. J. Biol. Chem., 2000, 275(36), 28128-28138.
79. Duester, G.; Mic, F.A.; Molotkov, A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissuespecific metabolism to retinoic acid. Chem. Biol. Interact., 2003, 143-144, 201-210. (Pubitemid 36246442)
80. Repa, J.J.; Hanson, K.K.; Clagett-Dame, M. All-trans-retinol is a ligand for the retinoic acid receptors. Proc. Natl. Acad. Sci. U.S.A., 1993, 90(15), 7293-7297. (Pubitemid 23222436)
81. Schmidt, C.K.; Brouwer, A.; Nau, H. Chromatographic analysis of endogenous retinoids in tissues and serum. Anal. Biochem., 2003, 315(1), 36-48. (Pubitemid 36379104)
82. Brtko, J.; Thalhamer, J. Renaissance of the biologically active vitamin A derivatives: Established and novel directed therapies for cancer and chemoprevention. Curr. Pharm. Des., 2003, 9(25), 2067-2077. (Pubitemid 37139084)
83. Rastinejad, F.; Wagner, T.; Zhao, Q.; Khorasanizadeh, S. Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J., 2000, 19(5), 1045-1054. (Pubitemid 30119829)
84. Bourguet, W.; Vivat, V.; Wurtz, J.M.; Chambon, P.; Gronemeyer, H.; Moras, D. Crystal structure of a heterodimeric complex of RAR and RXR ligandbinding domains. Mol. Cell, 2000, 5(2), 289-298. (Pubitemid 30628087)
85. Gampe, R.T. Jr.; Montana, V.G.; Lambert, M.H.; Wisely, G.B.; Milburn, M.V.; Xu, H.E. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes. Dev., 2000, 14(17), 2229-2241.
86. Kliewer, S.A.; Umesono, K.; Heyman, R.A.; Mangelsdorf, D.J.; Dyck, J.A.; Evans, R.M. Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc. Natl. Acad. Sci. U.S.A., 1992, 89(4), 1448-1452.
87. Lee, S.K.; Na, S.Y.; Kim, H.J.; Soh, J.; Choi, H.S.; Lee, J.W. Identification of critical residues for heterodimerization within the ligand-binding domain of retinoid X receptor. Mol. Endocrinol. Baltimore., Md., 1998, 12(3), 325-332. (Pubitemid 30666263)
88. Gampe, R.T. Jr.; Montana, V.G.; Lambert, M.H.; Miller, A.B.; Bledsoe, R.K.; Milburn, M.V.; Kliewer, S.A.; Willson, T.M.; Xu, H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell, 2000, 5(3), 545-555.
89. Nishikawa, J.; Kitaura, M.; Matsumoto, M.; Imagawa, M.; Nishihara, T. Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer. Nucleic Acids Res., 1994, 22(15), 2902-2907.
90. Honkakoski, P.; Zelko, I.; Sueyoshi, T.; Negishi, M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbitalresponsive enhancer module of the CYP2B gene. Mol. Cell Biol., 1998, 18(10), 5652-5658. (Pubitemid 28450516)
91. Claudel, T.; Leibowitz, M.D.; Fievet, C.; Tailleux, A.; Wagner, B.; Repa, J.J.; Torpier, G.; Lobaccaro, J.M.; Paterniti, J.R.; Mangelsdorf, D.J.; Heyman, R.A.; Auwerx, J. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc. Natl. Acad. Sci. U.S.A., 2001, 98(5), 2610-2615. (Pubitemid 32209530)
92. Mader, S.; Chen, J.Y.; Chen, Z.; White, J.; Chambon, P.; Gronemeyer, H. The patterns of binding of RAR, RXR and TR homo- And heterodimers to direct repeats are dictated by the binding specificites of the DNA binding domains. EMBO J., 1993, 12(13), 5029-5041. (Pubitemid 23358491)
93. Perlmann, T.; Jansson, L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes. Dev., 1995, 9(7), 769-782.
94. Leo, C.; Chen, J.D. The SRC family of nuclear receptor coactivators. Gene, 2000, 245(1), 1-11. (Pubitemid 30125358)
95. Chen, H.; Lin, R.J.; Schiltz, R.L.; Chakravarti, D.; Nash, A.; Nagy, L.; Privalsky, M.L.; Nakatani, Y.; Evans, R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell, 1997, 90(3), 569-580. (Pubitemid 27347246)
96. Arias, J.; Alberts, A.S.; Brindle, P.; Claret, F.X.; Smeal, T.; Karin, M.; Feramisco, J.; Montminy, M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature, 1994, 370(6486), 226-229. (Pubitemid 24236780)
97. Yuan, W.; Condorelli, G.; Caruso, M.; Felsani, A.; Giordano, A. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem., 1996, 271(15), 9009-9013. (Pubitemid 26123331)
98. Blanco, J.C.; Minucci, S.; Lu, J.; Yang, X.J.; Walker, K.K.; Chen, H.; Evans, R.M.; Nakatani, Y.; Ozato, K. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev., 1998, 12(11), 1638-1651. (Pubitemid 28299515)
99. Hong, H.; Kohli, K.; Trivedi, A.; Johnson, D.L.; Stallcup, M.R. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. U.S.A., 1996, 93(10), 4948-4952. (Pubitemid 26163504)
100. Voegel, J.J.; Heine, M.J.; Tini, M.; Vivat, V.; Chambon, P.; Gronemeyer, H. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and-independent pathways. EMBO J., 1998, 17(2), 507-519. (Pubitemid 28045491)
101. Le Douarin, B.; Zechel, C.; Garnier, J.M.; Lutz, Y.; Tora, L.; Pierrat, P.; Heery, D.; Gronemeyer, H.; Chambon, P.; Losson, R. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J., 1995, 14(9), 2020-2033.
102. Kim, Y.J.; Bjorklund, S.; Li, Y.; Sayre, M.H.; Kornberg, R.D. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell, 1994, 77(4), 599-608. (Pubitemid 24153999)
103. Kwon, H.; Imbalzano, A.N.; Khavari, P.A.; Kingston, R.E.; Green, M.R. Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature, 1994, 370(6489), 477-481. (Pubitemid 24263555)
104. Yoon, J.C.; Puigserver, P.; Chen, G.; Donovan, J.; Wu, Z.; Rhee, J.; Adelmant, G.; Stafford, J.; Kahn, C.R.; Granner, D.K.; Newgard, C.B.; Spiegelman, B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature, 2001, 413(6852), 131-138. (Pubitemid 32867868)
105. Kurotaki, N.; Harada, N.; Yoshiura, K.; Sugano, S.; Niikawa, N.; Matsumoto, N. Molecular characterization of NSD1, a human homologue of the mouse Nsd1 gene. Gene, 2001, 279(2), 197-204. (Pubitemid 33132181)
106. Zhao, H.H.; Herrera, R.E.; Coronado-Heinsohn, E.; Yang, M.C.; Ludes- Meyers, J.H.; Seybold-Tilson, K.J.; Nawaz, Z.; Yee, D.; Barr, F.G.; Diab, S.G.; Brown, P.H.; Fuqua, S.A.; Osborne, C.K. Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. J. Biol. Chem., 2001, 276(30), 27907-27912.
107. Dong, D.; Ruuska, S.E.; Levinthal, D.J.; Noy, N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J. Biol. Chem., 1999, 274(34), 23695-23698.
108. Lee, S.K.; Jung, S.Y.; Kim, Y.S.; Na, S.Y.; Lee, Y.C.; Lee, J.W. Two distinct nuclear receptor-interaction domains and CREB-binding proteindependent transactivation function of activating signal cointegrator-2. Mol. Endocrinol. Baltimore., Md., 2001, 15(2), 241-254. (Pubitemid 32128705)
109. Xu, W.; Chen, H.; Du, K.; Asahara, H.; Tini, M.; Emerson, B.M.; Montminy, M.; Evans, R.M. A transcriptional switch mediated by cofactor methylation. Science, 2001, 294(5551), 2507-2511. (Pubitemid 34027283)
110. Ayer, D.E. Histone deacetylases: Transcriptional repression with SINers and NuRDs. Trends Cell Biol., 1999, 9(5), 193-198. (Pubitemid 29192987)
111. Wei, L.N.; Hu, X.; Chandra, D.; Seto, E.; Farooqui, M. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem., 2000, 275(52), 40782-40787. (Pubitemid 32054897)
112. Mathur, M.; Tucker, P.W.; Samuels, H.H. PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol. Cell Biol., 2001, 21(7), 2298-2311. (Pubitemid 32222084)
113. Zamir, I.; Dawson, J.; Lavinsky, R.M.; Glass, C.K.; Rosenfeld, M.G.; Lazar, M.A. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc. Natl. Acad. Sci. U.S.A., 1997, 94(26), 14400-14405. (Pubitemid 28041385)
114. Burris, T.P.; Nawaz, Z.; Tsai, M.J.; O'Malley, B.W. A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors. Proc. Natl. Acad. Sci. U.S.A., 1995, 92(21), 9525-9529.